Patrick Zueger

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

Iain B. McInnes, J. Anderson, Marina Magrey et al. · New England Journal of Medicine · 2021 · 276 citations · Full text

Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2

Philip J. Mease, Apinya Lertratanakul, J. Anderson et al. · Annals of the Rheumatic Diseases · 2020 · 224 citations · Full text

Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study

Iain B. McInnes, Koji Kato, Marina Magrey et al. · RMD Open · 2021 · 85 citations · Full text

Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study

Philip J. Mease, Apinya Lertratanakul, Kim Papp et al. · Rheumatology and Therapy · 2021 · 73 citations · Full text

Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study

Daniel Aletaha, Andrew J. Epstein, Martha Skup et al. · Advances in Therapy · 2019 · 57 citations · Full text